Godlike Productions - Discussion Forum
Users Online Now: 2,141 (Who's On?)Visitors Today: 451,266
Pageviews Today: 759,176Threads Today: 307Posts Today: 4,874
09:56 AM


Back to Forum
Back to Forum
Back to Thread
Back to Thread
REPLY TO THREAD
Subject EBOLA Out-of-Control Outbreak in Africa. Fed Halts Vaccine R&D. Agenda 21?
User Name
 
 
Font color:  Font:








In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article.
Original Message

Page 18, Rockefeller Foundation Report

LOCK-STEP SCENARIO

In 2012, the pandemic that the world had been
anticipating for years finally hit.




[link to www.rockefellerfoundation.org]











August 6, 2012
Tekmira Provides Update on Collaboration With U.S. Government's TMT Program

VANCOUVER, British Columbia, Aug. 6, 2012 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced that it has received a temporary stop-work order from the U.S. Department of Defense (DoD) with respect to Tekmira's TKM-Ebola program. Other contractors have received similar notices as the DoD is under recently imposed funding constraints.

"During the two years of our collaboration with the U.S. DoD's Transformational Medical Technologies Program, we have a developed a strong working relationship that has fostered advances in our TKM-Ebola program and our LNP platform. Due to budgetary pressure in the U.S., we understand that the DoD must complete a thorough assessment of its ongoing programs. We expect a decision by September 1, 2012 on the future direction of our collaboration," said Dr. Mark J. Murray, Tekmira's President and CEO.

It is expected that by September 1, 2012, Tekmira will receive notification whether the DoD will cancel the stop-work order; terminate the contract; or extend the stop-work order period, if necessary.

TKM-Ebola is being developed under a contract awarded by the U.S. Government's Transformational Medical Technologies (TMT) Program to advance an RNAi therapeutic utilizing Tekmira's LNP technology to treat Ebola virus infection.

[link to investor.tekmirapharm.com]
Pictures (click to insert)
5ahidingiamwithranttomatowtf
bsflagIdol1hfbumpyodayeahsure
banana2burnitafros226rockonredface
pigchefabductwhateverpeacecool2tounge
 | Next Page >>





GLP